Plerixafor is a small-molecule inhibitor of C-X-C chemokine receptor type 4 (CXCR4) that functions as a hematopoietic stem cell mobilizer. It is used to stimulate the release of stem cells from the bone marrow into the blood in patients with non-Hodgkin’s lymphoma (NHL) and multiple myeloma to stimulate their immune system. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Mozobil and RPA bicyclam. Its PubChem CID is 65015.
Plerixafor
| CAS No | 110078-46-1 |
|---|---|
| Molecular Formula | C28H54N8 |
| Molecular Weight | 502.8 g/mol |
| Synonyms | 1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Plerixafor is a small-molecule inhibitor of C-X-C chemokine receptor type 4 (CXCR4) that functions as a hematopoietic stem cell mobilizer.
The listed CAS number is 110078-46-1.
The listed molecular formula is C28H54N8.
The listed molecular weight is 502.8 g/mol.
1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane.
The source lists Mozobil and RPA bicyclam.